Exact Mass: 357.2012092

Exact Mass Matches: 357.2012092

Found 97 metabolites which its exact mass value is equals to given mass value 357.2012092, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(S)-Laudanosine

1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline

C21H27NO4 (357.19399820000007)


(S)-Laudanosine is found in opium poppy. (S)-Laudanosine is an alkaloid from Papaver somniferum (opium poppy Alkaloid from Papaver somniferum (opium poppy). (S)-Laudanosine is found in opium poppy. D002491 - Central Nervous System Agents DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1]. DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1].

   

Nalbuphine

(1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18)-triene-10,14,17-triol

C21H27NO4 (357.19399820000007)


Nalbuphine is only found in individuals that have used or taken this drug. It is a narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. [PubChem]The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AF - Morphinan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Proteinase inhibitor E 64

3-[[[(1S)-1-[[[4-[(aminoiminomethyl)amino]butyl]amino]carbonyl]-3-methylbutyl]amino]carbonyl]-(2S,3S)-oxiranecarboxylic acid

C15H27N5O5 (357.2012092)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents KEIO_ID E015; [MS2] KO008950 KEIO_ID E015

   

N-Desmethyltamoxifen

(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)(methyl)amine

C25H27NO (357.20925320000003)


N-Desmethyltamoxifen is only found in individuals that have used or taken Tamoxifen. N-Desmethyltamoxifen is a metabolite of Tamoxifen. N-desmethyltamoxifen belongs to the family of Stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

5-hydroxypropafenone

1-{5-hydroxy-2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one

C21H27NO4 (357.19399820000007)


5-hydroxypropafenone is a metabolite of propafenone. Propafenone is a class of anti-arrhythmic medication, which treats illnesses associated with rapid heart beats such as atrial and ventricular arrhythmias. (Wikipedia) D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

(2R,3R)-3-[[(2S)-1-[4-(Diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid

(2R,3R)-3-[[(2S)-1-[4-(Diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid

C15H27N5O5 (357.2012092)


   

delta-9-tetrahydrocannabinolate

1-Hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromene-2-carboxylic acid

C22H29O4 (357.2065734)


delta9-tetrahydrocannabinolate is also known as thca or δ9-tetrahydrocannabinolic acid. delta9-tetrahydrocannabinolate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). delta9-tetrahydrocannabinolate can be found in a number of food items such as devilfish, arrowhead, potato, and cereals and cereal products, which makes delta9-tetrahydrocannabinolate a potential biomarker for the consumption of these food products.

   

(E)-(4-Acetoxycinnamoyl)-epilupinine

(E)-(4-Acetoxycinnamoyl)-epilupinine

C21H27NO4 (357.19399820000007)


   
   
   

Oroboidin|pyrrole-3-carboxylic acid 13-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester

Oroboidin|pyrrole-3-carboxylic acid 13-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester

C20H27N3O3 (357.20523120000007)


   

methyl 4-((E)-2-acetyl-4-oxonon-1-enyl)-6-((E)-prop-1-enyl)nicotinate|monascopyridine E|Monasnicotinate A

methyl 4-((E)-2-acetyl-4-oxonon-1-enyl)-6-((E)-prop-1-enyl)nicotinate|monascopyridine E|Monasnicotinate A

C21H27NO4 (357.19399820000007)


   
   
   
   

asparagylprolyllysine

asparagylprolyllysine

C15H27N5O5 (357.2012092)


   
   
   

Laudanosine

DL-LAUDANOSINE

C21H27NO4 (357.19399820000007)


D002491 - Central Nervous System Agents Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.628 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.624 Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2441; CONFIDENCE confident structure DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1]. DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1].

   

nalbuphine

nalbuphine

C21H27NO4 (357.19399820000007)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AF - Morphinan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

5-hydroxypropafenone

5-hydroxypropafenone

C21H27NO4 (357.19399820000007)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

Laudanoside

Laudanoside

C21H27NO4 (357.19399820000007)


Origin: Plant; Formula(Parent): C21H27NO4; Bottle Name:Laudanosine; PRIME Parent Name:Laudanosine; PRIME in-house No.:V0357; SubCategory_DNP: Isoquinoline alkaloids, Morphine alkaloids

   

Gly Gly Lys Pro

(2S)-1-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanoyl]pyrrolidine-2-carboxylic acid

C15H27N5O5 (357.2012092)


   

Gly Gly Pro Lys

(2S)-6-amino-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}hexanoic acid

C15H27N5O5 (357.2012092)


   

Gly Lys Gly Pro

(2S)-1-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H27N5O5 (357.2012092)


   

Gly Lys Pro Gly

2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H27N5O5 (357.2012092)


   

Gly Pro Gly Lys

(2S)-6-amino-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)hexanoic acid

C15H27N5O5 (357.2012092)


   

Gly Pro Lys Gly

2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]acetic acid

C15H27N5O5 (357.2012092)


   
   

Lys Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

C15H27N5O5 (357.2012092)


   

Lys Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2,6-diaminohexanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

C15H27N5O5 (357.2012092)


   

Lys Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

C15H27N5O5 (357.2012092)


   
   

Pro Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)hexanoic acid

C15H27N5O5 (357.2012092)


   

Pro Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}hexanamido]acetic acid

C15H27N5O5 (357.2012092)


   
   

Pro Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]acetamido}acetic acid

C15H27N5O5 (357.2012092)


   
   

butyl prop-2-enoate,prop-2-enenitrile,prop-2-enoic acid,styrene

butyl prop-2-enoate,prop-2-enenitrile,prop-2-enoic acid,styrene

C21H27NO4 (357.19399820000007)


   

N,N-dibenzyl-1-(phenylmethoxymethyl)cyclopropan-1-amine

N,N-dibenzyl-1-(phenylmethoxymethyl)cyclopropan-1-amine

C25H27NO (357.20925320000003)


   

tert-Butyl 6-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 6-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C20H28BNO4 (357.21112780000004)


   

tert-Butyl 6-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 6-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C20H28BNO4 (357.21112780000004)


   

tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C20H28BNO4 (357.21112780000004)


   

(R)-1,1,2-TRIPHENYL-2-(PIPERIDIN-1-YL)ETHANOL

(R)-1,1,2-TRIPHENYL-2-(PIPERIDIN-1-YL)ETHANOL

C25H27NO (357.20925320000003)


   

(S)-1,1,2-TRIPHENYL-2-(PIPERIDIN-1-YL)ETHANOL

(S)-1,1,2-TRIPHENYL-2-(PIPERIDIN-1-YL)ETHANOL

C25H27NO (357.20925320000003)


   
   
   

9-[3-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE MONOHYDROCHLORIDE

9-[3-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE MONOHYDROCHLORIDE

C21H28ClN3 (357.19716380000006)


   

(R)-laudanosine

(R)-laudanosine

C21H27NO4 (357.19399820000007)


A benzylisoquinoline alkaloid that is (R)-tetrahydropapaverine in which the amino hydrogen has been replaced by a methyl group

   

delta-9-tetrahydrocannabinolate

1-Hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromene-2-carboxylic acid

C22H29O4 (357.2065734)


delta9-tetrahydrocannabinolate is also known as thca or δ9-tetrahydrocannabinolic acid. delta9-tetrahydrocannabinolate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). delta9-tetrahydrocannabinolate can be found in a number of food items such as devilfish, arrowhead, potato, and cereals and cereal products, which makes delta9-tetrahydrocannabinolate a potential biomarker for the consumption of these food products. Δ9-tetrahydrocannabinolate is also known as thca or δ9-tetrahydrocannabinolic acid. Δ9-tetrahydrocannabinolate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Δ9-tetrahydrocannabinolate can be found in a number of food items such as devilfish, arrowhead, potato, and cereals and cereal products, which makes Δ9-tetrahydrocannabinolate a potential biomarker for the consumption of these food products.

   

Cannabichromenate

Cannabichromenate

C22H29O4- (357.2065734)


A hydroxy monocarboxylic acid anion that is the conjugate base of cannabichromenic acid, obtained by deprotonation of the carboxy group. Major species at pH 7.3.

   

Cannabidiolate

Cannabidiolate

C22H29O4- (357.2065734)


A dihydroxybenzoate that is the conjugate base of cannabidiolic acid, obtained by deprotonation of the carboxy group.

   
   

Delta(9)-tetrahydrocannabinolate

Delta(9)-tetrahydrocannabinolate

C22H29O4- (357.2065734)


A hydroxy monocarboxylic acid anion that is the conjugate base of Delta(9)-tetrahydrocannabinolic acid, obtained by deprotonation of the carboxy group.

   

(4Z)-6-{3-[(1E,3E,5Z,7E,9S,11Z)-9-hydroxytetradeca-1,3,5,7,11-pentaen-1-yl]oxiran-2-yl}hex-4-enoate

(4Z)-6-{3-[(1E,3E,5Z,7E,9S,11Z)-9-hydroxytetradeca-1,3,5,7,11-pentaen-1-yl]oxiran-2-yl}hex-4-enoate

C22H29O4- (357.2065734)


   

4,5-epoxy-17R-hydroxy-docosahexaenoate

4,5-epoxy-17R-hydroxy-docosahexaenoate

C22H29O4- (357.2065734)


   

7(8)-epoxy-17R-hydroxy-docosahexaenoate

7(8)-epoxy-17R-hydroxy-docosahexaenoate

C22H29O4- (357.2065734)


   

4(5)-epoxy-17S-hydroxy-docosahexaenoate

4(5)-epoxy-17S-hydroxy-docosahexaenoate

C22H29O4- (357.2065734)


   

N-[[(1R,2R)-3-Oxo-2-[(Z)-2-pentenyl]cyclopentan-1-yl]acetyl]-L-phenylalanine

N-[[(1R,2R)-3-Oxo-2-[(Z)-2-pentenyl]cyclopentan-1-yl]acetyl]-L-phenylalanine

C21H27NO4 (357.19399820000007)


   

N-[[(1R)-3-Oxo-2alpha-[(Z)-2-pentenyl]cyclopentane-1alpha-yl]acetyl]-L-phenylalanine

N-[[(1R)-3-Oxo-2alpha-[(Z)-2-pentenyl]cyclopentane-1alpha-yl]acetyl]-L-phenylalanine

C21H27NO4 (357.19399820000007)


   

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]-3-phenylpropanoic acid

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]-3-phenylpropanoic acid

C21H27NO4 (357.19399820000007)


   

delta-9-tetrahydrocannabinolate

delta-9-tetrahydrocannabinolate

C22H29O4- (357.2065734)


   
   

(4R,4aS,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol

(4R,4aS,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol

C21H27NO4 (357.19399820000007)


   

(4R,4aS,7S,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol

(4R,4aS,7S,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol

C21H27NO4 (357.19399820000007)


   
   

2-Oxospartein-13-yl 1H-pyrrole-2-carboxylate

2-Oxospartein-13-yl 1H-pyrrole-2-carboxylate

C20H27N3O3 (357.20523120000007)


   

6-Amino-2-methyl-8-(4-propan-2-ylphenyl)-1,3,8,8a-tetrahydroisoquinoline-5,5,7-tricarbonitrile

6-Amino-2-methyl-8-(4-propan-2-ylphenyl)-1,3,8,8a-tetrahydroisoquinoline-5,5,7-tricarbonitrile

C22H23N5 (357.1953358)


   

9alpha-Hydroxy-3-oxo-23,24-bisnorchola-1,4-dien-22-oate(1-)

9alpha-Hydroxy-3-oxo-23,24-bisnorchola-1,4-dien-22-oate(1-)

C22H29O4- (357.2065734)


   

3-Hydroxy-9-oxo-9,10-seco-23,24-bisnorchola-1,3,5(10)-trien-22-oate

3-Hydroxy-9-oxo-9,10-seco-23,24-bisnorchola-1,3,5(10)-trien-22-oate

C22H29O4- (357.2065734)


   

N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide

N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide

C17H23N7O2 (357.1913138)


   
   
   

(1S,2aR,8bR)-4-[cyclobutyl(oxo)methyl]-1-(hydroxymethyl)-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-4-[cyclobutyl(oxo)methyl]-1-(hydroxymethyl)-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C20H27N3O3 (357.20523120000007)


   

(1R,2aS,8bS)-4-[cyclobutyl(oxo)methyl]-1-(hydroxymethyl)-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-4-[cyclobutyl(oxo)methyl]-1-(hydroxymethyl)-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C20H27N3O3 (357.20523120000007)


   
   
   
   
   
   

(S)-Laudanosine

(S)-Laudanosine

C21H27NO4 (357.19399820000007)


D002491 - Central Nervous System Agents

   

e-64

e-64

C15H27N5O5 (357.2012092)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

   

N-Desmethyltamoxifen

N-Desmethyltamoxifen

C25H27NO (357.20925320000003)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   
   
   
   
   

(1r,3r,4s,5s,8r,9s,11s,14s,17s,18r)-3,4-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,16-dione

(1r,3r,4s,5s,8r,9s,11s,14s,17s,18r)-3,4-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,16-dione

C21H27NO4 (357.19399820000007)


   

dimethyl(2-{4,13,14-trimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-7-yl}ethyl)amine

dimethyl(2-{4,13,14-trimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-7-yl}ethyl)amine

C21H27NO4 (357.19399820000007)


   

(1r)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinoline

(1r)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinoline

C21H27NO4 (357.19399820000007)


   

5-hydroxy-4-(1-hydroxy-2,4-dimethyloct-6-en-1-ylidene)-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

5-hydroxy-4-(1-hydroxy-2,4-dimethyloct-6-en-1-ylidene)-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H27NO4 (357.19399820000007)


   

(4e)-5-hydroxy-4-[(6e)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(4e)-5-hydroxy-4-[(6e)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H27NO4 (357.19399820000007)